The role of infiltrating lymphocytes in the neo-adjuvant treatment of women with HER2-positive breast cancer
Alex J. Eustace(Royal College of Surgeons in Ireland), Bryan T. Hennessy(Royal College of Surgeons in Ireland)
Cited by 7
Related Papers
Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer
|Clinical Cancer Research|2016|1.2k
Characterization of a Naturally Occurring Breast Cancer Subset Enriched in Epithelial-to-Mesenchymal Transition and Stem Cell Characteristics
|Cancer Research|2009|857
Proteomic and transcriptomic profiling reveals a link between the PI3K pathway and lower estrogen-receptor (ER) levels and activity in ER+ breast cancer
|Breast Cancer Research|2010|258